Zynerba Pharmaceuticals Inc

NASDAQ:ZYNE  
3.60
-0.08 (-2.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Zynerba Pharmaceuticals Inc Stock, NASDAQ:ZYNE

80 West Lancaster Avenue, Suite 300, Devon, Pennsylvania 19333
United States of America
Phone: +1.484.581.7505
Number of Employees: 26

Description

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. The firm offers Zygel product, which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.